L
Luechai Sringernyuang
Researcher at Mahidol University
Publications - 18
Citations - 340
Luechai Sringernyuang is an academic researcher from Mahidol University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 7, co-authored 11 publications receiving 232 citations.
Papers
More filters
Journal ArticleDOI
Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China.
TL;DR: Stigma and discrimination against drug abusers and people living with HIV/AIDS (PLHA) in a Dai minority nationality community in Yunnan, China revealed deeply entrenched stigma and overt discrimination that manifested in familial, work, civil and institutional contexts.
Journal ArticleDOI
Stigmatization of AIDS patients : disentangling Thai nursing students' attitudes towards HIV/AIDS, drug use and commercial sex
TL;DR: Although AIDS was shown to be stigmatizing in and of itself, it was significantly less stigmatizing than IDU, highlighting the need to consider the non-disease-related stigmas associated with HIV as well as the actual stigma of HIV/AIDS in treatment and care settings.
Journal ArticleDOI
Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy
Claas Kirchhelle,Paul Atkinson,Alex Broom,Komatra Chuengsatiansup,Jorge Pinto Ferreira,Nicolas Fortané,Isabel Frost,Isabel Frost,Christoph Gradmann,Stephen Hinchliffe,Steven J. Hoffman,Javier Lezaun,Susan Nayiga,Kevin Outterson,Scott H. Podolsky,Stephanie Raymond,Adam P. Roberts,Andrew C. Singer,Anthony D. So,Luechai Sringernyuang,Elizabeth Tayler,Susan Rogers Van Katwyk,Clare I R Chandler +22 more
TL;DR: This multidisciplinary paper proposes three hallmarks that can support robust international antibiotic policy that are Structural, Equitable and Tracked and describes these hallmarks and propose their consideration should aid the design and evaluation of international antibiotic policies with maximal benefit at both local and international scales.
Journal ArticleDOI
One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission.
Ross D. Booton,Aronrag Meeyai,Aronrag Meeyai,Nour Alhusein,Henry Buller,Edward J. Feil,Helen Lambert,Skorn Mongkolsuk,Emma Pitchforth,Kristen K. Reyher,Walasinee Sakcamduang,Jutamaad Satayavivad,Andrew C. Singer,Luechai Sringernyuang,Visanu Thamlikitkul,Lucy Vass,Matthew B. Avison,Katherine Mary Elizabeth Turner,Boonrat Chantong,Nisanart Charoenlap,Natacha Couto,Punyawee Dulyayangkul,Marjorie J. Gibbon,Virginia C. Gould,Varapon Montrivade,Kornrawan Phoonsawad,Nuchanart Rangkadilok,Parntep Ratanakorn,Kwanrawee Sirikanchana,Tawit Suriyo,Sarin Suwanpakdee,Kantima Wichuwaranan,Anuwat Wiratsudakul +32 more
TL;DR: In this article, a model of ABU, gut colonisation with extended-spectrum beta-lactamase (ESBL)-producing bacteria and transmission was calibrated using estimates of the prevalence of ESBL-producing bacteria in Thailand.
Posted ContentDOI
One Health drivers of antibacterial resistance: quantifying the relative impacts of human, animal and environmental use and transmission
Ross D. Booton,Aronrag Meeyai,Aronrag Meeyai,Nour Alhusein,Henry Buller,Edward J. Feil,Helen Lambert,Skorn Mongkolsuk,Emma Pitchforth,Kristen K. Reyher,Walasinee Sakcamduang,Jutamaad Satayavivad,Andrew C. Singer,Luechai Sringernyuang,Visanu Thamlikitkul,Lucy Vass,Matthew B. Avison,Katherine Mary Elizabeth Turner +17 more
TL;DR: A mathematical model of antibacterial use, gut colonisation with extended-spectrum beta-lactamase-producing bacteria and faecal/oral transmission between populations of humans, animals and the environment was used to estimate the long-term impact of the NSP-AMR intervention and quantify the relative impacts of each driver on human ABR.